Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: An examination of 13,469 surgical patients

Annals of Surgical Oncology

Volumn 16, Issue 1, 2009, Pages 3-13

  Cheung, Michael C ^a   Hamilton, Kara ^a   Sherman, Recinda ^a   Byrne, Margaret M ^a   Nguyen, Dao M ^a   Franceschi, Dido ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Outcomes; Teaching; Volume

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; RACE; SEX; SMOKING; SURVIVAL TIME; TEACHING HOSPITAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; CANCER CARE FACILITIES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLORIDA; HOSPITALS, TEACHING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PULMONARY SURGICAL PROCEDURES; QUALITY ASSURANCE, HEALTH CARE; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE;

EID: 58549111383     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0025-9     Document Type: Article

References (42)

1. A Jemal R Siegel E Ward 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
2. I Gkiozos A Charpidou K Syrigos 2007 Developments in the treatment of non-small cell lung cancer Anticancer Res 27 2823 7
3. WK Lam DN Watkins 2007 Lung cancer: future directions Respirology 12 471 7
4. HS Luft JP Bunker AC Enthoven 1979 Should operations be regionalized? The empirical relation between surgical volume and mortality N Engl J Med 301 1364 9
5. HS Luft 1980 The relation between surgical volume and mortality: an exploration of causal factors and alternative models Med Care 18 940 59
6. CB Begg LD Cramer WJ Hoskins 1998 Impact of hospital volume on operative mortality for major cancer surgery JAMA 280 1747 51
7. JD Birkmeyer Y Sun SL Wong 2007 Hospital volume and late survival after cancer surgery Ann Surg 245 777 83
8. JC Gutierrez EA Perez D Franceschi 2007 Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry J Surg Res 141 105 14
9. PB Bach LD Cramer D Schrag 2001 The influence of hospital volume on survival after resection for lung cancer N Engl J Med 345 181 8
10. EL Hannan M Radzyner D Rubin 2002 The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer Surgery 131 6 15
11. JC Gutierrez EA Perez FL Moffat 2007 Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients Ann Surg 245 952 8
12. SF Khuri SF Najjar J Daley 2001 Comparison of surgical outcomes between teaching and nonteaching hospitals in the Department of Veterans Affairs Ann Surg 234 370 82 discussion 382-3
13. BS Knipp GM Deeb RL Prager 2007 A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States Surgery 142 524 8
14. GL Colice S Shafazand JP Griffin 2007 Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition) Chest 132 161 77S
15. RA Meguid BS Brooke DC Chang 2008 Are surgical outcomes for lung cancer resections improved at teaching hospitals? Ann Thorac Surg 85 1015 24 discussion 1024-5
16. PS Romano DH Mark 1992 Patient and hospital characteristics related to in-hospital mortality after lung cancer resection Chest 101 1332 7
17. AT Schroen RD Cress 2001 Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study Ann Surg 234 641 51
18. JL Freixinet G Julia-Serda PM Rodriguez 2006 Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases Eur J Cardiothorac Surg 29 20 5
19. BA Keagy ME Lores PJ Starek 1985 Elective pulmonary lobectomy: factors associated with morbidity and operative mortality Ann Thorac Surg 40 349 52
20. F Nagasaki BJ Flehinger N Martini 1982 Complications of surgery in the treatment of carcinoma of the lung Chest 82 25 9
21. R Wahi MJ McMurtrey LF DeCaro 1989 Determinants of perioperative morbidity and mortality after pneumonectomy Ann Thorac Surg 48 33 7
22. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89-108
23. MA Beckles SG Spiro GL Colice 2003 The physiologic evaluation of patients with lung cancer being considered for resectional surgery Chest 123 105 14S
24. R Arriagada B Bergman A Dunant 2004 Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 351 60
25. JY Douillard R Rosell M De Lena 2006 Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719 27
26. H Kato Y Ichinose M Ohta 2004 A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 1713 21
27. GV Scagliotti R Fossati V Torri 2003 Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer J Natl Cancer Inst 95 1453 61
28. Strauss GMHJE, Maddaus MA, Johnstone DW, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of cancer and leukemia group B (CALGB) protocol 9633. J Clin Oncol, 2006; ASCO Annual Meeting Proceedings Part I 2006; 24(No. 18S)
29. T Winton R Livingston D Johnson 2005 Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2589 97
30. JR Brahmer DS Ettinger 2007 Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy Respirology 12 320 5
31. L Horn A Sandler 2007 Lung cancer adjuvant therapy Cancer J 13 210 6
32. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol, 2006; ASCO Annual Meeting Proceedings Part I 2006; 24(No. 18S):7008
33. JC Gutierrez N Kassira RM Salloum 2007 Surgery for rectal cancer performed at teaching hospitals improves survival and preserves continence J Gastrointest Surg 11 1441 8 discussion 1448-50
34. EA Perez JC Gutierrez X Jin 2007 Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination J Gastrointest Surg 11 114 25
35. EA Perez AS Livingstone D Franceschi 2006 Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors J Am Coll Surg 202 623 9
36. N Hodgson LG Koniaris AS Livingstone 2005 Gastric carcinoids: a temporal increase with proton pump introduction Surg Endosc 19 1610 2
37. EA Perez LG Koniaris SE Snell 2007 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly World J Surg 31 1022 30
38. CS Chen TC Liu HC Lin 2008 Does high surgeon and hospital surgical volume raise the five-year survival rate for breast cancer? A population-based study Breast Cancer Res Treat 110 2 349 56
39. CC Lin HC Lin 2008 Effects of surgeon and hospital volume on 5-year survival rates following oral cancer resections: the experience of an Asian country Surgery 143 343 51
40. McKay A, You I, Bigam D, et al. Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol 2008
41. HC Wen CH Tang HC Lin 2006 Association between surgeon and hospital volume in coronary artery bypass graft surgery outcomes: a population-based study Ann Thorac Surg 81 835 42
42. S Xirasagar YC Lien HC Lin 2008 Procedure volume of gastric cancer resections versus 5-year survival Eur J Surg Oncol 34 23 9